临床实践中卒中前残疾患者取栓后功能结局的预测因素
研究基于Codi Ictus Catalunya登记,纳入2487例前循环闭塞取栓患者,其中409例(17.1%)存在卒中前残疾(mRS 2或3)。校正协变量后,卒中前残疾与90天良好功能结局无显著关联(24% vs 30%;OR 0.79 [0.57-1.08]),但与症状性颅内出血(5% vs 3%;OR 2.04 [1.11-3.72])和长期死亡率(31% vs 18%;OR 1.74 [1.27-2.39])风险升高独立相关。无糖尿病、ASPECTS>8且NIHSS<17的卒中前残疾患者取栓后安全性和结局与无残疾患者相似。
要点
- 卒中前残疾患者取栓后恢复至卒中前mRS的比例与无残疾患者相当。
- 卒中前残疾与症状性颅内出血和长期死亡率升高独立相关。
- 无糖尿病、ASPECTS>8且NIHSS<17的残疾患者取栓后结局与无残疾者相似。
核心结论
- 尽管死亡率和症状性颅内出血风险更高,卒中前残疾患者取栓后恢复至卒中前功能水平的比例与独立患者相当。
- 数据支持对前循环大血管闭塞后存在轻中度残疾的患者进行取栓可能获益。
研究设计与样本
- 研究为基于Codi Ictus Catalunya登记的前瞻性、政府强制、医院为基础的数据集分析。
- 卒中前残疾定义为mRS评分2或3,409例(17.1%)存在卒中前残疾(313例mRS 2,96例mRS 3)。
- 90天功能结局由加泰罗尼亚卒中项目盲法评估者集中评估。
- 采用逻辑回归分析卒中前残疾与结局的关联,并识别取栓后良好结局的残疾患者特征。
主要发现
- 校正协变量后,卒中前残疾与90天良好结局(至少恢复至卒中前mRS)无显著关联(24% vs 30%;OR 0.79 [0.57-1.08])。
- 卒中前残疾与症状性颅内出血风险升高独立相关(5% vs 3%;OR 2.04 [1.11-3.72])。
- 卒中前残疾与长期死亡率升高独立相关(31% vs 18%;OR 1.74 [1.27-2.39])。
- 无糖尿病、ASPECTS>8且NIHSS<17的卒中前残疾患者取栓后安全性和结局与无残疾患者相似。
关键数值与推荐
- 卒中前残疾定义为mRS评分2或3。
- 良好结局定义为90天至少恢复至卒中前mRS水平。
- 卒中前残疾患者90天良好结局率24%,无残疾患者30%(OR 0.79 [0.57-1.08])。
- 卒中前残疾患者症状性颅内出血率5%,无残疾患者3%(OR 2.04 [1.11-3.72])。
- 卒中前残疾患者长期死亡率31%,无残疾患者18%(OR 1.74 [1.27-2.39])。
临床怎么用
- 对前循环大血管闭塞的轻中度卒中前残疾患者,取栓可考虑作为治疗选择。
- 卒中前残疾患者取栓后需警惕症状性颅内出血和死亡风险升高。
- 无糖尿病、ASPECTS>8且NIHSS<17的卒中前残疾患者取栓后结局与无残疾者相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Mechanical thrombectomy (MT) in ischemic stroke patients with poor prestroke conditions remains controversial. We aimed to analyze the frequency of previously disabled patients treated with MT in clinical practice, the safety and clinical response to MT of patients with preexisting disability, and the disabled patient characteristics associated with a better response to MT. METHODS: We studied all consecutive patients with anterior circulation occlusion treated with MT from January 2017 to December 2019 included in the Codi Ictus Catalunya registry-a government-mandated, prospective, hospital-based data set. Prestroke disability was defined as modified Rankin Scale score 2 or 3. Functional outcome at 90 days was centrally assessed by a blinded evaluator of the Catalan Stroke Program. Favorable outcome (to return at least to prestroke modified Rankin Scale at 90 days) and safety and secondary outcomes were compared with patients without previous disability. Logistic regression analysis was used to assess the association between prestroke disability and outcomes and to identify a disabled patient profile with favorable outcome after MT. RESULTS: Of 2487 patients included in the study, 409 (17.1%) had prestroke disability (313 modified Rankin Scale score 2 and 96 modified Rankin Scale score 3). After adjustment for covariates, prestroke disability was not associated with a lower chance of achieving favorable outcome at 90 days (24% versus 30%; odds ratio, 0.79 [0.57-1.08]), whereas it was independently associated with a higher risk of symptomatic intracranial hemorrhage (5% versus 3%; odds ratio, 2.04 [1.11-3.72]) and long-term mortality (31% versus 18%; odds ratio, 1.74 [1.27-2.39]) compared with patients without disability. Prestroke disabled patients without diabetes, Alberta Stroke Program Early CT Score >8 and National Institutes of Health Stroke Scale score <17 showed similar safety and outcome results after MT as patients without prestroke disability. CONCLUSIONS: Despite a higher mortality and risk of symptomatic intracranial hemorrhage, prestroke-disabled patients return as often as independent patients to their prestroke level of function, especially those nondiabetic patients with favorable early ischemic signs profile. These data support a potential benefit of MT in patients with previous mild or moderate disability after large anterior vessel occlusion stroke.
引用
- Millán M, Ramos-Pachón A, Dorado L, et al. Predictors of Functional Outcome After Thrombectomy in Patients With Prestroke Disability in Clinical Practice. Stroke. 2021. PMID: 34702065. doi:10.1161/STROKEAHA.121.034960
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。